ITF Therapeutics
The Regional Business Director will lead a team of Key Account Managers to drive regional sales performance, team development, and execution of business strategies for a rare disease therapy. This remote role focuses on expanding adoption of an approved treatment for Duchenne muscular dystrophy across institutional and community settings.
Headquarters
Concord, Massachusetts, United States
Company Size
1-10 employees
Founded
2024
ITF Therapeutics LLC is a division of Italfarmaco S.p.A., based in the United States and focused on bringing proven treatments to people living with rare diseases. The company commercializes DUVYZAT (givinostat), an FDA-approved HDAC inhibitor for Duchenne muscular dystrophy (DMD), in the U.S. market. ITF Therapeutics combines patient advocacy, medical research support, and community engagement to serve rare disease patients, clinicians, and researchers.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for ITF Therapeutics.
36% above the average for this role
Rare Disease Account Manager- Gulf Coast Region
IQVIA
Rare Disease Account Manager- North Central Region
IQVIA
Rare Disease Account Manager- Northeast Region
IQVIA
Rare Disease Account Manager- Pacific Region
IQVIA
Rare Disease Account Manager- Atlantic Region
IQVIA
Rare Disease Account Manager- Mountain West Region
IQVIA